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A nerve growth factor receptor encoded by the
TRKA gene plays an important part in the formation
of autonomic neurons and small sensory neurons in
dorsal root ganglia and in signal transduction through
its intracytoplasmic tyrosine kinase domain. Recently,
three mutations in the tyrosine kinase domain of
TRKA have been reported in patients with congenital
insensitivity to pain with anhidrosis, which is an
autosomal recessive disorder characterized by recur-
rent fever due to absence of sweating, no reaction
to noxious stimuli, self-mutilating behavior, and
mental retardation. We examined the TRKA gene
in five generations of a large Japanese family with
many consanguineous marriages who live in a small
Congenital insensitivity to pain with anhidrosis (CIPA)(MIM no. 256800) is an autosomal recessive disorder,characterized by the absence of pain and temperaturesensation and lack of sweating (Swanson, 1963;McKusick, 1998). Patients have recurrent episodes
of unexplained fever, repeated traumatic and thermal injuries, self-
mutilating behavior, and occasionally mental retardation.
Nerve growth factor (NGF) and its high affinity receptor, TRKA,
play an important part in the development and function of sensory
and sympathetic neurons (Snider, 1994; Davies, 1994). NGF induces
neurite outgrowth and promotes survival of embryonic sensory and
sympathetic neurons (Levi-Montalcini, 1987). TRKA, a receptor
tyrosine kinase originally cloned from a human colon cancer
(Martin-Zanca et al, 1986) is expressed in the nervous system
(Martin-Zanca et al, 1990) and is phosphorylated in response to
NGF (Kaplan et al, 1991; Klein et al, 1991). Mice lacking TrkA
have severe sensory and sympathetic neuropathies and most die
within 1 mo of birth (Smeyne et al, 1994). They have extensive
neuroneal cell loss in trigeminal, sympathetic, and dorsal root
ganglia, as well as a decrease in the cholinergic basal forebrain
projections to the hippocampus and cortex (Smeyne et al, 1994).
As these gene knockout mice including NGF knockout mice
(Crowley et al, 1994), have phenotypes similar to the human
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remote island of the southern part of Japan. We
found a novel point mutation at nucleotide 1825
(A→G transition) resulting in Met-581-Val in the
tyrosine kinase domain. Two of the three affected
patients were homozygous for this mutation; how-
ever, the third affected patient was heterozygous.
Further analysis revealed that the third patient was
a compound heterozygote with the Met-581-Val
mutation in one allele and with a single base C
deletion mutation at nucleotide 1726 in exon 14 in
the other allele, resulting in a frameshift and
premature termination codon. Key words: nerve growth
factor/nerve growth factor receptor/type IV hereditary
sensory neuropathy. J Invest Dermatol 112:810–814, 1999
genetic disease, hereditary sensory neuropathies, Indo et al (1996)
examined these genes and discovered mutations of the TRKA gene
in patients with hereditary sensory neuropathies type IV, i.e., CIPA.
Interestingly, all three mutations found in the TRKA gene, a
deletion, splice, and mis-sense mutation, were in the intracyto-
plasmic tyrosine kinase domain, which is thought to be related to
intracellular signal transduction. Their findings strongly suggested
that defects in TRKA cause CIPA and that the NGF-TRKA system
has a crucial part in the development and function of the nociceptive
reception system as well as in the establishment of thermal regulation
via sweating in humans. Similar findings that a mutation of a
receptor tyrosine kinase for glial cell derived neurotrophic factor
(GDNF), RET, causes abnormal enteric neurite outgrowth was
reported in Hirschsprung’s disease (Romeo et al, 1994; Schuchardt
et al, 1994). These reports suggest that receptor tyrosine-kinase genes
function during embryogenesis of the mammalian nervous system.
Here we report the case of an individual who was thought to
have suffered from CIPA and whose TRKA gene was found to be
mutated. Furthermore, we demonstrated that the patient is large
family contained two individuals who had a novel mis-sense
mutation, which was homozygous and one who was a compound
heterozygote.
MATERIALS AND METHODS
Clinical family history We encountered a 57 y old female who was
born and grew up on a remote island in the southern part of Japan as
shown in Fig 1, IV-5. She had episodes of recurrent fever, hypohidrosis,
hypalgesia, multiple joint dislocations, bone fractures, and mild mental
retardation, although she had normal temperature sensation (Fig 2a). Skin
biopsy showed that her eccrine glands were morphologically normal. A
careful electron microscopic search revealed no nerve endings in the sweat
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Figure 1. Pedigree and genotype of Met-581-Val mutation and del
C1726 mutation in the TRKA gene of the CIPA family over five
generations. Proband (IV-5) is indicated by an arrow. Asterisks represent
affected patients. Half-black circles and squares represent heterozygous
carriers, black circles represent homozygous patients with the Met-581-Val
mutation in the TRKA gene. Half-hatched square represents heterozygous
carriers, half-hatched and black circle represents a compound heterozygote
of the del C1726 and Met-581-Val mutations in the TRKA gene. Figures
with diagonal lines represent deceased individuals. The ages of the family
members tested are shown.
glands, as previously reported (Langer et al, 1981). Iodine-starch test showed
no sweating, and her body temperature rose from 35.6°C to 36.9°C in a
44°C room in 5 min. A lack of physiologic sweat gland response was
demonstrated by subcutaneous injection of 1:10,000 acetylcholine. Thus,
she was shown to have neurogenic anhidrosis. X-ray examination of bones
demonstrated an acetabular dysplasia of the left coxa, absence of a part of
the left femoral head (Fig 2b), and a dislocation and/or deformity of the
ankle joint. She had a vocabulary IQ of 68. Neurologically, diminished
tendon stretch reflexes and pathologic reflex on the left side were noted.
Painful stimuli failed to evoke a withdrawal response. The difference
between cool (10°C water) and tepid (45°C water) was recognized when
tubes containing water at these temperatures were in contact with her
extremities and trunk. These suggested a neurologic abnormality similar
to CIPA. As shown in Fig 1, she had a large family with many
consanguineous marriages in which there were at least three patients. The
father and mother of the proband (IV-4) are first cousins, while the father
of the second patient (V-3) is also a first cousin and her mother the product
of a first cousin/aunt marriage. Similarly, the third patient (V-1) is closely
related, maternally, but outbred, paternally. IV-4 (Fig 2a, b) and V-3
(Fig 2c) were unmarried and were bedridden and had similar symptoms.
V-1, however, who is married and has a daughter, has similar symptoms
to the two others except for mental retardation. Sixteen individuals
representing four generations were available for DNA analysis (Fig 1).
PCR and DNA sequencing for mutation detection After informed
consent was obtained, blood samples were collected and genomic DNA
was extracted from the buffy coats (QIAGEN, Hilden, Germany). As a
control, genomic DNA from 51 normal healthy Japanese people were
used. Specific primers (Int-3; 59-TCCTGTCCCTGCCGCTTCCA-39
and Int-1; 59-CTATGTTCACACATCTGCCT-39) for amplification of
exon 14 used in this study are those which had been reported (Indo et al,
1996). Amplification conditions were 95°C for 1 min, followed by 35
cycles of 94°C for 40 s, 60°C for 40 s, and 72°C for 1 min, and then final
extension at 72°C for 3 min. PCR products (377 bp) were cloned into
TA vector (Invitrogen, San Diego, CA) and sequenced with the Dye
Terminator Cycle Sequencing Ready Reaction (Perkin Elmer, Warrington,
U.K.) and an ABI 310 autosequencer.
Restriction enzyme digestion for DNA diagnosis The Met-581-Val
mutation abolished one of the two NlaIII restriction enzyme sites in the
377 bp fragment, which enabled us to distinguish a mutant allele (289 and
88 bp fragments) from the wild-type allele (226, 88, and 63 bp fragments).
The single base C deletion at nucleotide 1726 (del C1726) results in a loss
of one of the three restriction enzyme sites for Bsp1286I in the 377 or
Figure 2. Clinical appearance and X-ray finding of patients with
CIPA. The proband (IV-5) (a, b) and the patient (V-3) (c) show that
the joint destruction caused by the failure to react to painful stimuli was
the most prominent feature.
366 bp fragment, which allowed us to distinguish a mutant allele (241, 96,
and 39 bp fragments) from the normal allele (194, 96, 48, and 39 bp
fragments). Digestion with these restriction enzymes was done according
to the manufacturer’s recommendations (New England Biolabs, Beverly,
MA). The digested samples were examined by electrophoresis on 3%
agarose gels.
RESULTS
Identification of a novel point mutation in exon 14 of the
intracytoplasmic tyrosine kinase domain The entire exon 14
with flanking segments of the TRKA gene from the genomic
DNA of patients IV-5 and V-3 and normal healthy controls was
amplified, cloned into the vector, and sequenced. Results of the
sequence in both patients (IV-5 and V-3) revealed a novel point
mutation at nucleotide 1825 (A→G transition) resulting in Met-
581-Val in the tyrosine kinase domain in contrast with that of
normal controls (Fig 3a). The Met-581-Val mutation abolished
one of the two NlaIII restriction enzyme sites in the 377 bp PCR
products, which enabled us to distinguish a mutant allele (289 and
88 bp fragments) from the wild-type allele (226, 88, and 63 bp
fragments) (Fig 3b). NlaIII digestion of the 377 bp PCR product
(Fig 3c) revealed whether or not individual family members
had this mutation (Figs 1 and 3c). The proband (IV-5) was
homozygous for the mutation (data not shown). Patient V-3 with
consanguineous parents was homozygous for this mutation, while
her father (III-12), mother (IV-10), and aunt (III-11) were hetero-
zygous, and her uncle (IV-9) and others did not carry the mutation
(Fig 3c). This mutation was not detected in genomic DNA from
51 control subjects.
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Figure 3. The proband and the patient V-3 were homozygous for the Met-581-Val mutation. (a) Sequence analysis of exon 14 and the flanking
intronic sequence of the TRKA gene from genomic DNA reveals a homozygous A-to-G transition (asterisks) at position 1825 in the mutant allele (lower
panel) as compared with the normal control sequence (upper panel). The mutation changes codon ATG to GTG (Met-581-Val). (b) Scheme of the fragment
pattern of the PCR products formed by restriction enzyme NlaIII digestion. The nucleotide substitution abolishes a NlaIII restriction enzyme site. In a
normal allele, the 377 bp PCR product is digested to 226, 88, and 63 bp fragments, whereas in a mutant allele, 289 and 88 bp fragments appear. (c)
Restriction enzyme digestion analysis of the genomic region around the mutation in family members III-11, III-12, IV-9, IV-10, and V-3 as shown in
Fig 1. The 377 bp PCR products were digested with NlaIII and electrophoresed on a 3% agarose gel. Analysis of the PCR product for each individual
is shown below the corresponding symbols in the pedigree. M, molecular marker; U, undigested PCR product; C, normal control individual.
Identification of a compound heterozygote in the same
family The third 37 y old female patient (V-1) in the same family
was heterozygous for the Met-581-Val mutation (Fig 1). As we
expected to detect another mutation in this patient (V-1) as a
compound heterozygote, PCR products with the same primers
(Int-3 and Int-1) from the genomic DNA of the patient (V-1) and
her father (IV-3) were cloned into the TA vector and sequenced.
The sequences revealed a single base C deletion mutation at
nucleotide 1726 in exon 14 (Fig 4a), resulting in a frameshift and
premature termination codon. This del C1726 mutation was seen
in five of seven clones from the patient (V-1) and in six of eight
clones from her father (IV-3). This mutation was not detected in
the healthy controls (Fig 4a) as also reported elsewhere (Indo et al,
1996). The del C1726 mutation results in a loss of one of the three
restriction enzyme sites for Bsp1286I in the 377 or 366 bp fragment,
which allowed us to distinguish a mutant allele (241, 96, and 39 bp
fragments) from a normal allele (194, 96, 48, and 39 bp fragments)
(Fig 4b). The patient (V-1) and her father (IV-3) were heterozygous
for the del C1726 mutation, while her mother (IV-4) did not carry
it (Fig 4c, lower panel). On the other hand, the patient (V-1)
and her mother (IV-4) were heterozygous for the Met-581-Val
mutation, while her father (IV-3) did not carry it (Fig 4c, upper
panel). Therefore, we concluded that this patient (V-1) was a
compound heterozygote with a combination of the Met-581-Val
mutation and the del C1726 mutation.
DISCUSSION
CIPA is a rare clinical disorder, only 32 cases have been reported
in the literature most of which were children, in contrast to our
adult cases. In addition to the three mutations previously reported
(Indo et al, 1996), we found a novel point mutation and the first
case of a compound heterozygote in the same family (Table I).
All three mutations in Japanese cases were in exon 14, while a
point mutation resulting exon 15 skipping in Ecuadorian cases was
in the splice-donor site in intron 15. Because the affected patients
had characteristic clinical symptoms and features, all the family
members know the symptoms of the disease well. The affected
patients could not feel pain, especially from bone fractures. There-
fore, they easily developed bone deformities from suppurative
arthritis, osteomyelitis and joint dislocation of hands, elbows, knees,
and ankles. Sensory neurons which innervate periosteum and joint
capsules seem to be affected as are those in skin and muscle. As
the homozygous patients with the Met-581-Val mutation have
relatively long survival and have normal temperature sensation, the
substitution from methionine to valine at position 581 in TRKA
in this family might cause milder clinical symptoms as compared
with others (Vardy et al, 1979; Ishii et al, 1988; Indo et al, 1996).
The characteristic clinical features in our three Japanese patients
are: (i) they are adult cases; (ii) familial incidence is present, which
is rare in Japanese cases reported (Ishii et al, 1988); (iii) they lacked
impairment of temperature sense; and (iv) the third patient (V-1)
obviously lacked mental retardation.
Both dorsal root and sympathetic ganglia arise from the neural
crest (Brown and Podosin, 1966). In the chick embryo, tactile
exteroceptive cells appear at 2.5–6 d, nociceptive and proprio-
ceptive cells at 10 d over the early differentiation of neural crest
cells (Hamberger and Levi-Montalcini, 1949). The timing of the
onset of the disorder may critically determine the degree of system
involvement (Brown and Podosin, 1966). A congenital defect
in the neural crest, causing defective development of pain and
temperature afferent neurons and efferent sympathetic neurons to
sweat glands, might explain the syndrome in these patients (Swan-
son, 1963; Swanson et al, 1965). With light microscopy eccrine
sweat glands appeared to be morphologically normal; however, we
could not find the nerve fiber which should reach the secretary
portion of eccrine sweat glands by electron microscope (data not
shown). These data suggest that the NGF-TRKA system is related
to the formation or extension of neural fibers during development
in the early embryonal period.
Of interest is that the homozygote of the Met-581-Val mutation
had mental retardation but the heterozygote for the Met-581-Val
and del C1726 mutations did not. More than 90% of CIPA
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Figure 4. The third patient V-1 is a compound heterozygote for the Met-581-Val mutation and the del C1726 mutation in exon 14. (a)
Sequence analysis of exon 14 and the flanking intronic sequence of the TRKA gene from genomic DNA reveals a deletion of a single base C at nucleotide
1726 (asterisks) in the mutant allele (lower panel) as compared with the normal control sequence (upper panel), causing a frameshift and premature termination
codon downstream. (b) Scheme of the fragment pattern of the PCR products formed by digestion with restriction enzyme Bsp1286I. The nucleotide
deletion abolishes a Bsp1286I restriction enzyme site. In a normal allele, the 377 bp PCR product is digested to 194, 96, 48, and 39 bp fragments,
whereas in the mutant allele, 241, 96, and 39 bp fragments appear after Bsp1286I digestion. (c) Restriction enzyme digestion analysis of the genomic
region around the mutation in family members IV-3, IV-4, and V-1 as shown in Fig 1. PCR products of 377 and 366 bp were digested with NlaIII
(upper panel), and with Bsp1286I (lower panel), and electrophoresed on a 3% agarose gel, respectively. Analysis of the PCR product for each individual is
shown below the corresponding symbols in the pedigree. Solid halves represent the maternally inherited Met-581-Val mutation; striped halves represent
the paternally inherited del C1726 mutation. M, molecular marker.
Table I. TRKA gene mutations found in CIPA patients
Origin of family Nucleotide change Predicted effect on protein product Families Reference
Japan del C1726 Frameshift at residue 548 KI-01 homozygous Indo et al., 1996
Ecuador IVS1513, a→c exon 15 skipping GM08382 homozygous Indo et al., 1996
Japan C1795→G G571R KI-02 homozygous Indo et al., 1996
Japan A1825→G M581V homozygous this study
A1825→G/del C1726 M581V/Frameshift at residue 548 heterozygous this study
cases reported have mental retardation in spite of existence of
consanguinity. There were no other retards in the extended,
consanguineous family. It had been reported that the relationship
between forebrain contribution and mental retardation in neural
crest syndrome was not clear (Brown and Podosin, 1966). In
adult TrkA-deficient mice, cholinergic projections of the basal
forebrain to the hippocampus and cerebral cortex are severely
decreased (Smeyne et al, 1994). The third case (V-1) without
mental retardation suggest there is a possibility that the heterozygous
change of the TRKA in CNS may not affect the fiber outgrowth
or maintenance of the cholinergic phenotype. Although it is difficult
to explain the different phenotypic expression of the same gene
mutation, further investigation to detect the mutations of the
TRKA gene in patients with CIPA might reveal a correlation
between the pattern of the mutation and the phenotypic
involvement of the CNS.
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